Publications by authors named "Lingdao Sha"

Article Synopsis
  • Mesenchymal epithelial transition (MET) protein overexpression is an important target for drug development in non-small cell lung cancer, but challenges exist in identifying patients for treatment.
  • Current testing methods lack standardization and consume valuable tissue, prompting the need for better prediction techniques.
  • Researchers developed a weakly supervised model that uses standard H&E-stained slides to predict MET RNA overexpression, showing promising results that could help prioritize patients for further MET testing.
View Article and Find Full Text PDF

Background: Tumor programmed death-ligand 1 (PD-L1) status is useful in determining which patients may benefit from programmed death-1 (PD-1)/PD-L1 inhibitors. However, little is known about the association between PD-L1 status and tumor histopathological patterns. Using deep learning, we predicted PD-L1 status from hematoxylin and eosin (H and E) whole-slide images (WSIs) of nonsmall cell lung cancer (NSCLC) tumor samples.

View Article and Find Full Text PDF

Purpose: Large cell neuroblastomas (LCN) are frequently seen in recurrent, high-risk neuroblastoma but are rare in primary tumors. LCN, characterized by large nuclei with prominent nucleoli, predict a poor prognosis. We hypothesize that LCN can be created with high-dose intra-tumoral chemotherapy and identified by a digital analysis system.

View Article and Find Full Text PDF

Patient responses to cancer immunotherapy are shaped by their unique genomic landscape and tumor microenvironment. Clinical advances in immunotherapy are changing the treatment landscape by enhancing a patient's immune response to eliminate cancer cells. While this provides potentially beneficial treatment options for many patients, only a minority of these patients respond to immunotherapy.

View Article and Find Full Text PDF

Objective: To determine whether a computer vision-based approach applied to haematoxylin and eosin (H&E) prostate biopsy images can distinguish dutasteride-treated tissue from placebo, and identify features associated with degree of responsiveness to 5α-reductase inhibitor (5ARI) therapy.

Subjects And Methods: Our study population comprised 100 treatment-adherent men without prostate cancer assigned to dutasteride or placebo in the REDUCE trial, who had slides available from mandatory year-4 biopsies. Half of the men also provided slides from a year-2 biopsy.

View Article and Find Full Text PDF

Context: Color normalization techniques for histology have not been empirically tested for their utility for computational pathology pipelines.

Aims: We compared two contemporary techniques for achieving a common intermediate goal - epithelial-stromal classification.

Settings And Design: Expert-annotated regions of epithelium and stroma were treated as ground truth for comparing classifiers on original and color-normalized images.

View Article and Find Full Text PDF